Vernant Jp

3.5k total citations
66 papers, 2.0k citations indexed

About

Vernant Jp is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Vernant Jp has authored 66 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 15 papers in Oncology and 14 papers in Immunology. Recurrent topics in Vernant Jp's work include Hematopoietic Stem Cell Transplantation (25 papers), Acute Myeloid Leukemia Research (13 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Vernant Jp is often cited by papers focused on Hematopoietic Stem Cell Transplantation (25 papers), Acute Myeloid Leukemia Research (13 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Vernant Jp collaborates with scholars based in France, Switzerland and Italy. Vernant Jp's co-authors include Francesco Frassoni, Aloïs Gratwohl, J. Hermans, A Devergié, William Arcese, Enric Carreras, HJ Kolb, JM Goldman, T. de Witte and D Niederwieser and has published in prestigious journals such as Science, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Vernant Jp

64 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vernant Jp France 23 1.6k 652 442 426 305 66 2.0k
RC Ash United States 21 1.9k 1.2× 539 0.8× 434 1.0× 486 1.1× 723 2.4× 32 2.4k
Nadežda Basara Germany 23 1.4k 0.9× 610 0.9× 312 0.7× 520 1.2× 420 1.4× 70 2.1k
J P Vernant France 24 1.3k 0.8× 608 0.9× 365 0.8× 429 1.0× 638 2.1× 49 2.0k
Francis Witz France 19 1.3k 0.8× 759 1.2× 430 1.0× 414 1.0× 146 0.5× 54 2.0k
Edward Kanfer United Kingdom 26 1.1k 0.7× 250 0.4× 394 0.9× 477 1.1× 416 1.4× 55 1.8k
Yasunori Ueda Japan 20 1.1k 0.7× 699 1.1× 272 0.6× 410 1.0× 289 0.9× 115 1.6k
D I Marks United Kingdom 25 1.2k 0.7× 505 0.8× 241 0.5× 387 0.9× 462 1.5× 47 1.6k
Laurent Sutton France 26 1.3k 0.8× 327 0.5× 728 1.6× 1.1k 2.6× 546 1.8× 61 2.7k
Anna Paola Iori Italy 20 1.1k 0.7× 286 0.4× 300 0.7× 276 0.6× 298 1.0× 65 1.5k
E Racadot France 22 950 0.6× 324 0.5× 196 0.4× 339 0.8× 816 2.7× 98 2.0k

Countries citing papers authored by Vernant Jp

Since Specialization
Citations

This map shows the geographic impact of Vernant Jp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vernant Jp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vernant Jp more than expected).

Fields of papers citing papers by Vernant Jp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vernant Jp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vernant Jp. The network helps show where Vernant Jp may publish in the future.

Co-authorship network of co-authors of Vernant Jp

This figure shows the co-authorship network connecting the top 25 collaborators of Vernant Jp. A scholar is included among the top collaborators of Vernant Jp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vernant Jp. Vernant Jp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacque, Nathalie, Stéphanie Nguyen, J.‐L. Golmard, et al.. (2014). Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia. Bone Marrow Transplantation. 50(2). 259–265. 40 indexed citations
2.
Canals, Carmen, H. Schouten, Arnon Nagler, et al.. (2009). Allogeneic stem cell transplantation as salvage therapy in patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem cell transplantation. An analysis of the EBMT Registry. Bone Marrow Transplantation. 43. 2 indexed citations
3.
Tavernier, Emmanuelle, JM Boiron, Françoise Huguet, et al.. (2007). Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial. Leukemia. 21(9). 1907–1914. 184 indexed citations
4.
Gouill, Steven Le, Nöel Milpied, Agnès Buzyn, et al.. (2007). Allogeneic stem cell transplantation (allo-SCT) in T-cell lymphomas: A French national survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Journal of Clinical Oncology. 25(18_suppl). 8095–8095. 2 indexed citations
5.
Valteau-Couanet, D, Catherine Faucher, A. Aupérin, et al.. (2005). Cost effectiveness of day 5 G-CSF (Lenograstim®) administration after PBSC transplantation: results of a SFGM-TC randomised trial. Bone Marrow Transplantation. 36(6). 547–552. 30 indexed citations
6.
Jouet, J P, et al.. (2004). Evaluation of centre and period effects in allogeneic haematopoietic stem cell transplantation in France. Bone Marrow Transplantation. 34(7). 645–651. 5 indexed citations
7.
Rubio, Marie‐Thérèse, Nathalie Dhédin, Claude Boucheix, et al.. (2003). Adult T‐biphenotypic acute leukaemia: clinical and biological features and outcome. British Journal of Haematology. 123(5). 842–849. 28 indexed citations
8.
Jp, Vernant. (2002). [Work and nature in ancient Greece].. PubMed. 52(1). 18–38. 1 indexed citations
9.
Dhédin, Nathalie, Xavier Thomas, F. Huguet, et al.. (2002). No Superiority of Autologous Stem Cell Transplantation over Chemotherapy Alone in Adult Ph-Negative ALL in First Complete Remission A Long Follow-Up Report Combining Results of LALA 85, 87 and 94 Trials. Blood. 100(11). 81516. 2 indexed citations
10.
Pigneux, Arnaud, M-L. Tanguy, Mauricette Michallet, et al.. (2002). Prior treatment with alpha interferon does not adversely 
affect the outcome of allogeneic transplantation 
for chronic myeloid leukaemia. British Journal of Haematology. 116(1). 193–201. 15 indexed citations
11.
Gratwohl, Aloïs, J. Hermans, JM Goldman, et al.. (1998). Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. The Lancet. 352(9134). 1087–1092. 451 indexed citations
12.
13.
Socié, Gèrard, J Cahn, Vernant Jp, et al.. (1997). Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM). British Journal of Haematology. 97(4). 865–870. 96 indexed citations
14.
Ringdén, Olle, Myriam Labopin, Éliane Gluckman, et al.. (1997). Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Bone Marrow Transplantation. 19(10). 963–968. 36 indexed citations
15.
Gratwohl, Aloïs, J. Hermans, A. John Barrett, et al.. (1988). Allogeneic bone marrow transplantation for leukaemia in Europe. The Lancet. 1(8599). 1379–1382. 65 indexed citations
16.
Diviné, Marine, MF Gourdin, Tawfiq Henni, et al.. (1988). Functional analysis of CD8 lymphocytes in long-term surviving patients after bone marrow transplantation. Journal of Clinical Immunology. 8(2). 140–147. 8 indexed citations
17.
Troussard, X., et al.. (1985). Nécrose médullaire révélatrice de myélome multiple des os. La Presse Médicale. 14(36). 1888–1888. 4 indexed citations
18.
Jp, Vernant, et al.. (1983). Splenic rupture due to aspergillosis.. PubMed. 25(6). 385–6. 5 indexed citations
19.
Coscas, G, et al.. (1981). Obstruction choriocapillaire au cours de la maladie de Moschowitz (à propos de 2 cas: analyse angiographique et anatomopathologique).. Journal Français d Ophtalmologie. 4(2). 3 indexed citations
20.
Jp, Vernant, et al.. (1975). Acidose lactique au cours d'une leucémie aiguë. 126(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by RC Ash Breakdown of academic impact, for papers by Nadežda Basara Breakdown of academic impact, for papers by J P Vernant Breakdown of academic impact, for papers by Francis Witz Breakdown of academic impact, for papers by Edward Kanfer Breakdown of academic impact, for papers by Yasunori Ueda Breakdown of academic impact, for papers by D I Marks Breakdown of academic impact, for papers by Laurent Sutton Breakdown of academic impact, for papers by Anna Paola Iori Breakdown of academic impact, for papers by E Racadot
Rankless by CCL
2026